In this review:
- CheckMate 77T: Nivolumab
- KEYNOTE-671: Pembrolizumab
- CheckMate 861: Nivolumab and PD-L1 expression
- TROPION-Lung01: Datopotamab deruxtecan
- MARIPOSA: Amivantamab vs osimertinib
- MARIPOSA-2: Amivantamab post osimertinib
- PAPILLON: Amivantamab
- LIBRETTO-431: Selpercatinib
- ALINA: Alectinib
Please login below to download this issue (PDF)